- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/52 - Radicals substituted by nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 307/52
Total number of patents in this class: 554
10-year publication summary
|
45
|
53
|
43
|
43
|
52
|
31
|
40
|
16
|
28
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19839 |
18 |
| ADT Pharmaceuticals, LLC | 13 |
12 |
| Anji Pharmaceuticals Inc. | 34 |
8 |
| Corteva Agriscience LLC | 2660 |
8 |
| King Abdulaziz University | 508 |
7 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
7 |
| BASF SE | 20803 |
6 |
| Centre National de La Recherche Scientifique | 10350 |
6 |
| ChemoCentryx, Inc. | 389 |
6 |
| Drexel University | 983 |
6 |
| Mitsubishi Gas Chemical Company, Inc. | 3443 |
6 |
| The United States Government AS represented by The Department of Veterans Affairs | 1159 |
6 |
| Newmarket Pharmaceuticals LLC | 13 |
6 |
| Immunomet Therapeutics Inc. | 31 |
5 |
| Intervet Inc. | 896 |
5 |
| Rhodia Operations | 1581 |
5 |
| Exonate Limited | 15 |
5 |
| Shanghai Leado PharmaTech Co. Ltd. | 16 |
5 |
| Wisconsin Alumni Research Foundation | 3864 |
4 |
| Abbvie Inc. | 1803 |
4 |
| Other owners | 419 |